The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Glaxo Chair To Exit; William Hill Profit Down

Mon, 21st Jan 2019 07:59

LONDON (Alliance News) - Stock prices in London are set for a marginally higher open on Monday, with investors optimistic about US-China trade relations and hopeful for economic stimulus in China following weak 2018 growth figures.IG futures indicate the FTSE 100 index is to open 11.0 points higher at 6,979.33. The blue-chip index closed up 133.41 points, or 2.0%, at 6,968.33 on Friday. "Asian markets traded higher on Chinese stimulus hopes following slowing GDP growth. Investors also demonstrated confidence that trade tensions would ease as they looked towards talks later this month with optimism," said London Capital Group analyst Jasper Lawler.China's economy grew 6.6% in 2018, the country's statistics bureau said Monday, in the slowest rate since 1990.In the final quarter of 2018, the economy grew 6.4% amid signs the world's second-largest economy is slowing as China grapples with issues including the ongoing trade war with the US.Growth for 2019 is widely expected to fall to 6.5% or lower, according to the World Bank and economic experts.Premier Li Keqiang said Thursday that China would aim to keep growth within a "reasonable range" through innovation and macroeconomic policies, according to state news agency Xinhua.The economy has taken a hit from the US trade war, which if left unresolved past its March deadline for negotiations could further inhibit growth.The Japanese Nikkei 225 index ended up 0.3% Monday. In China, the Shanghai Composite ended up 0.6%, while the Hang Seng index in Hong Kong is up 0.4% in late trade.US markets will be closed Monday for the Martin Luther King Jr Day holiday. On Friday, Wall Street ended higher, with the Dow Jones Industrial Average closing 1.4% higher, the S&P 500 up 1.3%, and the Nasdaq Composite 1.0% higher.In early UK corporate news, the blue-chip pharmaceutical company GlaxoSmithKline said Non-Executive Chairman Philip Hampton will step down and the search for his successor has begun."Following the announcement of our deal with Pfizer Inc and the intended separation of the new consumer business, I believe this is the right moment to step down and allow a new chair to oversee this process through to its conclusion over the next few years and to lead the board into this next phase," Hampton said.In December, Glaxo announced that it will combine its consumer healthcare business with that of the US's Pfizer, creating a new joint venture. The combination will have sales of GBP9.8 billion, and GSK will have a majority controlling equity interest of 68%.Turning to London mid-caps, William Hill said it expects its adjusted operating profit for the year to January 1 to be GBP234 million, down 15% on the year prior. The result is in line with the betting company's operating profit guidance of GBP225 million to GBP245 million. More positively for William Hill, underlying operating profit increased 4% year-on-year, with the Online division delivering good growth. The company has also highlighted an "excellent" growth in the US and said it plans to invest in rapid expansion in the country.Separately, William Hill said it now holds 92% stake in online gambling company Mr Green & Co, and expects to secure the acceptances of its takeover offer for the remaining 8% interest by the end of January.Meanwhile, takeaway food delivery marketplace Just Eat said Chief Executive Officer Peter Plumb is stepping down from the board with immediate effect, and will be replaced by Chief Customer Officer Peter Duffy until the appointment of successor. The company also said that 2018 has been a transformational year, and it expects to report annual orders of 221 million, with revenue of GBP780 million, up from GBP546 million generated in 2017. Underlying earnings before interest, taxes, depreciation, and amortization is anticipated to total between GBP172 million and GBP174 million. In 2017, Just Eat reported underlying Ebitda of GBP164 million. Looking ahead, Just Eat expects to invest in the significant opportunity it sees in the high-growth markets of Brazil and Mexico. It also sees 2019 revenue in a range of GBP1.0 billion to GBP1.1 billion and underlying Ebitda of GBP185 million to GBP205 million. Components firm Meggitt said it signed a USD750 million contract with Pratt & Whitney to continue the supply of advanced composite components for the F119 and F135 engines which power the F-22 Raptor and F-35 Lightning II aircraft."These components will be produced in our new state-of-the-art facility in San Diego, California which opened in August 2018 to support the rapid growth in demand for advanced engine composite components across the aerospace industry," said Meggitt Chief Executive Tony Wood.Elsewhere, Patisserie Holdings confirmed it is still in talks with its bankers to extend the standstill of its bank facilities beyond January 18. On Sunday, The Times reported that the cake chains main trading subsidiary Patisserie Valerie has a potential to collapse as soon as Tuesday if emergency talks between major shareholder Luke Johnson and its lenders fail.The newspaper said Patisserie Valerie's Chair Johnson intends to extend a standstill agreement on the cake chain's bank facilities, which expired on Friday last week. If he fails, HSBC Holdings and Barclays could demand repayment of GBP9.7 million of overdraft debt.Turning to Brexit, May is to set out her next steps to build a Commons majority for a Brexit deal amid signs she is still unwilling to give ground on her central demands.Following the crushing defeat last week of her agreement with Brussels, the prime minister will make oral and written statements to the House explaining how she intends to proceed.She will also table a "neutral" motion to be debated and voted on - along with any amendments tabled by MPs - on January 29.Government sources said she would be holding further talks with MPs, as well as business leaders and trade unionists, throughout the week in an attempt to find a way forward.But after she briefed the Cabinet in a conference call on Sunday about her first round of cross-party contacts last week, there was little expectation she was ready to offer concessions that could win over opposition MPs.The pound was lower, quoted at USD1.2870 early Monday, soft compared to USD1.2897 at the close Friday.The economic events calendar Monday will see world leaders gather in Davos, Switzerland for the World Economic Forum starting on Tuesday.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.